These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27812217)
41. Reduction of polynitroaromatic compounds: the bacterial nitroreductases. Roldán MD; Pérez-Reinado E; Castillo F; Moreno-Vivián C FEMS Microbiol Rev; 2008 May; 32(3):474-500. PubMed ID: 18355273 [TBL] [Abstract][Full Text] [Related]
42. Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties. Fersing C; Boudot C; Paoli-Lombardo R; Primas N; Pinault E; Hutter S; Castera-Ducros C; Kabri Y; Pedron J; Bourgeade-Delmas S; Sournia-Saquet A; Stigliani JL; Valentin A; Azqueta A; Muruzabal D; Destere A; Wyllie S; Fairlamb AH; Corvaisier S; Since M; Malzert-Fréon A; Di Giorgio C; Rathelot P; Azas N; Courtioux B; Vanelle P; Verhaeghe P Eur J Med Chem; 2020 Nov; 206():112668. PubMed ID: 32795774 [TBL] [Abstract][Full Text] [Related]
43. Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India. Singh N; Sundar S Exp Parasitol; 2017 May; 176():30-45. PubMed ID: 28263760 [TBL] [Abstract][Full Text] [Related]
44. Design, Synthesis and Biological Evaluation of 7-arylbenzo[c]acridine-5,6- diones as Potential Anti-Leishmanial and anti-trypanosomal Agents. Mahajan S; Khan SI; Tekwani BL; Khan IA; Singh IP Med Chem; 2018; 14(6):563-572. PubMed ID: 29485004 [TBL] [Abstract][Full Text] [Related]
45. In vitro effects of anti-Trypanosoma cruzi compounds on HSP60 levels. Muelas-Serrano S; Pérez-Serrano J; Gómez-Barrio A; Ochoa C; Martínez J; Rodríguez-Caabeiro F Parasitol Res; 2001 Aug; 87(8):615-8. PubMed ID: 11510996 [TBL] [Abstract][Full Text] [Related]
46. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India. Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296 [TBL] [Abstract][Full Text] [Related]
47. SAR studies on azasterols as potential anti-trypanosomal and anti-leishmanial agents. Gigante F; Kaiser M; Brun R; Gilbert IH Bioorg Med Chem; 2009 Aug; 17(16):5950-61. PubMed ID: 19620005 [TBL] [Abstract][Full Text] [Related]
48. Enhancing the copy number of Ldrab6 gene in Leishmania donovani parasites mediates drug resistance through drug-thiol conjugate dependent multidrug resistance protein A (MRPA). Chauhan IS; Rao GS; Singh N Acta Trop; 2019 Nov; 199():105158. PubMed ID: 31491399 [TBL] [Abstract][Full Text] [Related]
49. Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity. Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Szular J; Kaiser M Eur J Med Chem; 2016 Nov; 123():895-904. PubMed ID: 27543881 [TBL] [Abstract][Full Text] [Related]
50. RES-Seq-a barcoded library of drug-resistant Tulloch LB; Carvalho S; Lima M; Wall RJ; Tinti M; Pinto EG; MacLean L; Wyllie S mBio; 2023 Nov; 14(6):e0180323. PubMed ID: 37929970 [TBL] [Abstract][Full Text] [Related]
51. The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance. Perea A; Manzano JI; Castanys S; Gamarro F Antimicrob Agents Chemother; 2016 Jun; 60(6):3489-96. PubMed ID: 27021316 [TBL] [Abstract][Full Text] [Related]
52. Physiological aspects of nitro drug resistance in Giardia lamblia. Müller J; Hemphill A; Müller N Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):271-277. PubMed ID: 29738984 [TBL] [Abstract][Full Text] [Related]
53. Mass spectrometry-based proteomic analysis of Leishmania donovani soluble proteins in Indian clinical isolate. Kumar A; Misra P; Sisodia B; Shasany AK; Sundar S; Dube A Pathog Dis; 2014 Feb; 70(1):84-7. PubMed ID: 24115687 [TBL] [Abstract][Full Text] [Related]
54. Ultrastructural alterations in ovaries from nifurtimox or benznidazole-treated rats: their relation to ovarian nitroreductive biotransformation of both drugs. de Castro CR; de Toranzo EG; Bernacchi AS; Carbone M; Castro JA Exp Mol Pathol; 1989 Jun; 50(3):385-97. PubMed ID: 2721655 [TBL] [Abstract][Full Text] [Related]
55. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent. Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of chalcones as potential antileishmanial agents. Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541 [TBL] [Abstract][Full Text] [Related]